Universe Pharmaceuticals INC (UPC)

UPC Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Revenue	26.73	32.31	40.14	47.98	30.7	33.23
Revenue Growth (YoY)	-22.33%	-19.52%	-16.34%	56.27%	-7.60%	16.54%
Cost of Revenue	19.17	21.99	18.25	22.66	16.61	19.82
Gross Profit	7.56	10.32	21.89	25.33	14.09	13.41
Selling, General & Admin	10.26	8.89	21.58	6.17	3.16	3.04
Research & Development	2.68	4.86	7.64	5.47	0.58	0.62
Other Operating Expenses	0.04	0.1	0.1	0.1	0.1	-
Operating Expenses	12.97	13.84	29.33	11.74	3.84	3.65
Operating Income	-5.42	-3.53	-7.44	13.59	10.25	9.75
Interest Expense	-0.35	-0.19	-0.2	-0.15	-0.16	-0.14
Interest & Investment Income	-	0.07	0.04	0.29	0.03	0.01
Earnings From Equity Investments	0.03	0.03	0.04	0.03	0.02	0.03
Other Non Operating Income (Expenses)	-0.1	-0.24	0.05	-0.08	-0.05	0
EBT Excluding Unusual Items	-5.83	-3.85	-7.51	13.68	10.1	9.66
Gain (Loss) on Sale of Investments	-10.71	-	-0.47	-	-	-
Gain (Loss) on Sale of Assets	-0	-0	-0	-0	-	-0
Pretax Income	-16.54	-3.85	-7.98	13.68	10.1	9.65
Income Tax Expense	2	2.31	0.75	2.36	2.54	2.1
Net Income	-18.55	-6.16	-8.74	11.32	7.56	7.55
Net Income to Common	-18.55	-6.16	-8.74	11.32	7.56	7.55
Net Income Growth	-	-	-	49.77%	0.09%	-0.68%
Free Cash Flow	-6.22	1.08	-1.41	-15.59	6.06	13.12
Gross Margin	28.27%	31.93%	54.53%	52.78%	45.90%	40.35%
Operating Margin	-20.27%	-10.92%	-18.53%	28.32%	33.39%	29.35%
Profit Margin	-69.41%	-19.08%	-21.76%	23.59%	24.62%	22.73%
Free Cash Flow Margin	-23.27%	3.33%	-3.50%	-32.48%	19.75%	39.48%
EBITDA	-4.92	-3.02	-6.9	14.04	10.66	10.17
EBITDA Margin	-18.39%	-9.34%	-17.20%	29.25%	34.73%	30.61%
D&A For EBITDA	0.5	0.51	0.53	0.45	0.41	0.42
EBIT	-5.42	-3.53	-7.44	13.59	10.25	9.75
EBIT Margin	-20.27%	-10.92%	-18.53%	28.32%	33.39%	29.35%
Effective Tax Rate	-	-	-	17.24%	25.17%	21.77%
Advertising Expenses	-	4.76	17.54	1.33	0.36	0.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q